Peepals Shakti · Topic
4 stories, newest first
A study of 52,330 Israeli women released on 2 November 2026 found modern hormone therapy started at 45 to 59 was not linked to more heart attacks or strokes.
The US FDA approved Zydus's generic Climara Pro on October 20, 2026, the first generic of the weekly hormone patch for menopause symptoms and bone loss.
ACOG's new menopause guidance, released October 15, 2026, drops the 'lowest dose, shortest time' hormone therapy rule and adds non-hormonal options.
A Nature Medicine study of 300 million lab tests from over a million women, reported on October 12, 2026, finds abrupt body-wide changes at menopause; some experts urge caution.
The most important, fact-checked stories from all seven publications, once a week.
